BGRSX
Price
$15.25
Change
-$0.00 (-0.00%)
Updated
Sep 20 closing price
DHLSX
Price
$29.97
Change
-$0.09 (-0.30%)
Updated
Sep 20 closing price
Ad is loading...

BGRSX vs DHLSX

Header iconBGRSX vs DHLSX Comparison
Open Charts BGRSX vs DHLSXBanner chart's image
Boston Partners Global Long/Short I
Price$15.25
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Diamond Hill Long-Short I
Price$29.97
Change-$0.09 (-0.30%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
BGRSX vs DHLSX Comparison Chart
Loading...
VS
BGRSX vs. DHLSX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGRSX is a Buy and DHLSX is a StrongBuy.

FUNDAMENTALS
Fundamentals
DHLSX has more cash in the bank: 1.83B vs. BGRSX (164M). DHLSX pays higher dividends than BGRSX: DHLSX (2.02) vs BGRSX (1.25). BGRSX was incepted earlier than DHLSX: BGRSX (10 years) vs DHLSX (20 years). BGRSX is a more actively managed with annual turnover of: 172.00 vs. DHLSX (41.00). BGRSX (2500) and DHLSX (2500) have matching initial minimum investment requirements. BGRSX (14.67) and DHLSX (14.57) have marching annual gain over last year. BGRSX return over 5 years is better than : 59.93 vs. DHLSX (12.27).
BGRSXDHLSXBGRSX / DHLSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years20 years-
Gain YTD10.62010.84398%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets164M1.83B9%
Annual Yield % from dividends1.252.0262%
Returns for 1 year14.6714.57101%
Returns for 3 years42.210.0665,862%
Returns for 5 years59.9312.27488%
Returns for 10 years66.9930.90217%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMPL33.600.09
+0.27%
Simply Good Foods Company (The)
NOK4.19N/A
N/A
Nokia Corp
EPM5.61-0.12
-2.09%
Evolution Petroleum Corp
AYTU2.47-0.06
-2.37%
Aytu BioPharma
CTKB5.06-0.28
-5.24%
Cytek Biosciences